Track abdominal pain location, bowel pattern, nausea, vomiting, bleeding, diet triggers, hydration, weight changes, medicines, procedures, and lab or imaging follow-up.
Condition detail
Pancreatitis
Pancreatitis is a digestive, liver, gallbladder, pancreas, or bowel condition tracked with pain location, meals, hydration, stool or vomiting changes, bleeding, medicines, procedures, and test follow-up.
Connected records
Database matches for this condition
Excessive thirst
Excessive thirst is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
Frequent hunger
Frequent hunger is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
High blood sugar symptoms
High blood sugar symptoms is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
Low blood sugar symptoms
Low blood sugar symptoms is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
Shakiness
Shakiness is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
Sweating episodes
Sweating episodes is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
Unintentional weight changes
Unintentional weight changes is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
Frequent urination
Frequent urination is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Sitagliptin and metformin hydrochloride
Used for: ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: ZITUVIMET is not recommended in patients with type 1 diabetes mellitus. ( 1 ) ZITUVIMET has not been studied in patients with a history of pancreatitis.